StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $406.23MP/E –Yield –

Vireo Growth free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Vireo Growth's free cash flow for the twelve months ending Jun 30, 2026 was -$116.31M. For fiscal 2025 it was -$24.61M. The highest annual figure on record is -$5.93M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.61M–
FY2024Dec 31, 2024-$21.93M–
FY2023Dec 31, 2023-$5.93M–
FY2022Dec 31, 2022-$23.63M–
FY2021Dec 31, 2021-$48.56M–
FY2020Dec 31, 2020-$19.38M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$105.80M–
Q1 FY2026Mar 31, 2026$1.10M–
Q4 FY2025Dec 31, 2025$8.79M–
Q3 FY2025Sep 30, 2025-$20.41M–
Q2 FY2025Jun 30, 2025-$8.50M–
Q1 FY2025Mar 31, 2025-$4.50M–
Q4 FY2024Dec 31, 2024-$9.16M–
Q3 FY2024Sep 30, 2024-$7.48M-597.5%
Q2 FY2024Jun 30, 2024-$3.20M–
Q1 FY2024Mar 31, 2024-$2.09M–
Q4 FY2023Dec 31, 2023-$2.79M–
Q3 FY2023Sep 30, 2023$1.50M–
Q2 FY2023Jun 30, 2023-$647.27K–
Q1 FY2023Mar 31, 2023-$3.99M–
Q4 FY2022Dec 31, 2022-$6.74M–
Q3 FY2022Sep 30, 2022-$3.13M–
Q2 FY2022Jun 30, 2022-$4.83M–
Q1 FY2022Mar 31, 2022-$8.93M–
Q4 FY2021Dec 31, 2021-$11.20M–
Q3 FY2021Sep 30, 2021-$8.84M–
Q2 FY2021Jun 30, 2021-$18.62M–
Q1 FY2021Mar 31, 2021-$9.90M–
Q4 FY2020Dec 31, 2020-$4.80M–
Q3 FY2020Sep 30, 2020-$5.68M–
Q2 FY2020Jun 30, 2020-$5.65M–
Q1 FY2020Mar 31, 2020-$3.24M–

More Vireo Growth figures

See a number that looks wrong?